• Valeant completes sale of Dendreon to Sanpower for $819.9m pharmaceutical-technology
    July 04, 2017
    Canadian company Valeant Pharmaceuticals International has completed the sale of all outstanding equity interests in its subsidiary Dendreon Pharmaceuticals to the Sanpower Group for $819.9m. 
PharmaSources Customer Service